Healthcare -
Biotechnology - NASDAQ - US
$ 1.185
-1.25 %
$ 76.1 M
Market Cap
-0.76
P/E
INZY - PRE-TAX INCOME
Pre-tax Income INZY - Inozyme Pharma, Inc.
-71.2 M
LAST VALUE
-12.11%
2 YEAR CAGR
-59.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR